Outcome of Board Meeting held on 13th February, 2026 for approval of Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2025
Awaiting price reaction for this filing.
The Board approved unaudited standalone financial results for Q3 FY26 and the nine months ended 31 December 2025, with a clean (unqualified) limited review report from K.N. Gutgutia & Co. Q3 revenue from operations rose sharply to Rs. 9,393 lakhs (vs Rs. 6,664 lakhs in Q3 FY25, ~41% YoY growth), driven almost entirely by the High Tension Insulators segment. Q3 net profit jumped to Rs. 1,469 lakhs (vs Rs. 46 lakhs YoY), reflecting a strong operational turnaround and significant EBITDA margin expansion in the insulator business. However, for the nine-month period, the company reported a net loss of Rs. 2,879 lakhs versus a profit of Rs. 2,630 lakhs in the prior year, primarily due to a one-time exceptional loss of Rs. 4,630 lakhs on the sale of its entire stake in subsidiary Hindusthan Speciality Chemicals Ltd (HSCL) to DCM Shriram Limited. EPS for Q3 stood at Rs. 101.82.
The underlying insulator business is showing a clear recovery with strong revenue growth and margin expansion, which is positive for the stock. The 9M headline loss is driven by a one-time divestment loss and is unlikely to recur, though investors should note pending items related to the HSCL sale, including an escrow of Rs. 3,980 lakhs held for tax claims and ongoing negotiations with DCM Shriram.